Merck
CN
高级检索
Chemical Structure Search
Search Within
文件类型

64-85-7

应用筛选条件
关键词:'64-85-7'
显示 1-30 共 439 条结果 关于 "64-85-7" 范围 技术文档
The Effective Use of Protein Kinase Inhibitors
2 5 . 5 8 3 2 84 99 99 9 64 59 20 90 93 80 94 103 96 52 55 89 82 89 99 94 102 95 86 101 105 106 34 37 57 87 81
SMC®Plate Washer Evaluation Kit
1 2 3 4 5 6 7 8 9 10 11 12 Row Mean SD CV A 68 65 86 57 71 79 61 79 59 69 59 82 70 10 14 B 79 55 63 62 60
Product Information Sheet-e64-ro
4. Supplementary Information y Version: 08E-64, Protease Inhibitor N-[N-(L-3-Trans-carboxirane-2-carbonyl)-L-leucyl]-agmatine sigma-aldrich.com 7 4. Supplementary Information 4.1. Conventions
Prohibited Product List Korean
PROPYN-1-OL FOR SYNTHESIS S Bulk 107-19-7 1차 2020-08-25 8.17043.1000.BWT 817043 THIMEROSAL PH EUR BP 1 KG
The Effective Use of Protein Kinase Inhibitors
www.sigma-aldrich.com/cellsignaling 84 99 99 9 64 59 20 90 93 80 94 103 96 52 55 89 82 89 99 94 102 95 86 101 105 106 34 37 57 87 81 26
Anti-Calpain-94 (LP828588 90 Isoforms) (Domain I) Large Subunit antibody produced in rabbit (C3739)
the LP 82, 85, 88, and 90 isoforms.2 The lens contains isoforms LP82 and LP85. The latent large subunit is 94 kDa, and the amino-terminal truncation at activation yields approximately 64-62 kDa isoforms
Complement C8 (C3535)
mass of 150 kDa. It has three nonidentical polypeptide chains: 1-3  -chain (64 kDa)  -chain (64 kDa)  -chain (22 kDa) Complement C8 is present in normal plasma at
Application Note Anaerobic EM using ICR+
87 Ø 78 74/64 89 0.4 1.0 – 1.1 1.5 B. fragilis ATCC 25285 51/59/68 Ø 56 75/52 108 0.4 – 0.5 1.4 – 1.5 1.9 – 2.0 C. macginleyii (in- house isolate) 54/59/56 Ø
Anti-Calpain-94 (Domain II) Large Submit antibody produced in rabbit (C3364)
Subunit detects all isoforms of human calpain 94, including the LP82, 85, 88, and 90 forms. The antibody also detects isoforms 82, 85, 88, and 90 of rat calpain 94. The antibody recognizes latent and active
Analysis of Antibiotic Sulfa Drugs Using Ascentis C18
, sulfamerazine, 127-79-7, S8876, sulfamethizole, 144-82-1, S5632, 581324-U Conditions column: Ascentis C18, 15 cm x 4.6 mm I.D., 5 µm particles (581324-U) mobile phase: 85:15, water with 1% acetic
Specialty Monomers For Ophthalmic Applications Brochure
www.sigmaaldrich.com/ophthalmic-monomers-contact 6 7 Product Name Product Grades Available CAS No. Complementary General Reagents Acetone FCC 67-64-1 Aluminum Oxide 1344-28-1 Acetic Acid Meets
Product Information Sheet-11836153001
incubation with the protease Pancreas extract 0.02 7.8 85 96 Pronase 0.005 7.8 92 98 Thermolysin 0.0005 7.8 98 98 Chymotrypsin 0.0015 7.8 85 93 0.003 7.8 90 93 Papain 0.33 7.8 66 77 The inhibitory
Data Sheet - P8208
storage, clarify the solution by centrifugation before use. References 1. Cantley, L., et al., Cell, 64, 281 (1991). 2. Otsu, M., et al., Cell, 65, 91 (1991). 3. Panayotou, C., and Waterfield, M., BioEssays
NovAseptic Mixer: Heatsink Tank Plate for GMP, GMP Ex ATEX, HS and USM Mixer, G94-###
229 (9.02) 224 (8.82) 29 (1.1) GM200/33 AX200/33 — GMP20000 & GMP20000 ATEX G94-007 64 (2.52) 229 (9.02) 224 (8.82) 29 (1.1) GM300/33 — — GMP30000 The life science business
LABORATORY NOTEBOOK ISSUANCE PAGE
.22 85 0.22 42 2.5 1,870 0.007 0.20 100 0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015
Lab Notebook Guidelines
.22 85 0.22 42 2.5 1,870 0.007 0.20 100 0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015
LABORATORY NOTEBOOK ISSUANCE PAGE
.22 85 0.22 42 2.5 1,870 0.007 0.20 100 0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015
LABORATORY NOTEBOOK ISSUANCE PAGE
.22 85 0.22 42 2.5 1,870 0.007 0.20 100 0.40 44 16 995 0.007 0.18 80 0.29 50 2.7 2,685 0.015 0.12 97 6 52 7 235 0.015 0.18 96 7 54 20–25 39 0.015
MILLIPLEX®MAP Human Myokine Panel is an optimized quantitative immunoassay that simultaneously measures 15 novel muscle-secreted factors
42 134 125 43 145 40 85 56 85 45 207 5751 std 6 180 97 200 138 278 392 75 286 154 276 184 306 64 352 8683 193 92 206 147 283 407 80 300
Dental Application Brochure
Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production 64-19-7 Agarose 9012-36-6 Benzoyl Peroxide 94-36-0 Calcium Hydroxide 1305-62-0 Glycerin Meets
Product Information Sheet - R5125
Product Information Ribonuclease A from bovine pancreas Sigma Type III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein R5125 Product Description CAS Registry Number
Product Information Sheet - C6143
solution. J. Pharm. Pharmacol., 32(7), 460-462 (1980). 9. Shaker, L.A., et al., Mechanism of resistance of Bacillus subtilis spores to chlorhexidine. J. Appl. Bacteriol., 64(6), 531-539 (1988). IRB
Specialty Materials For Dental Applications Brochure
Eur, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production 64-19-7 Agarose 9012-36-6 Benzoyl Peroxide 94-36-0 Calcium Hydroxide 1305-62-0 Glycerin Meets
A centrifugal ultrafiltration-based method for enrichment of microvesicles
82 64 Alix 96 kDa HSP70 70 kDa 82 64 49 1 2 3
DataSheet - P8340
Pittsburgh, M.S. thesis, p. 7 (2020). 6. Crosland, Rachel, "Studies of The PTEN Tumour Suppressor in Endometrial Cancer". Sheffield Hallam University, Ph.D. dissertation, p. 85 (2004).
Enhanced Sensitivity Immunogenicity (ADA) Assay - Next Generation SMC™ Technology
147 1.37 1 1 1 407 4.12 2 2 2 861 12.35 3 3 3 1214 37.04 7 6 6 2428 111.11 13 17 12 3417 333.33 34 45 45 3323 1000.00 50 61 85 3393 3000.00 64 97 116 2840 ADA ng/mL 1500 ng/mL B
Data Sheet - SAB4200728
., 3, R45-54 (2014). 5. Di Comite G., et al., J Leukoc Biol., 85, 81-7 (2009). 6. Baudin E., et al., Br J Cancer, 78, 1102-7 (1998). SG,DR_OKF/LV,PHC 04/17-1
Panorama Ab Microarray - Gene Regulation I List of Antibodies
clone: AH3-120 H0913 35 Acetyl&Phospho Histone H3 (pSer10, Ac-Lys9) clone: APH3-64 H0788 36 Acetyl-Histone H3 ( Ac-Lys9) H9286 37 Acetyl&Phospho Histone H3 (pSer10, Ac-Lys9) H9161
Data Sheet - P3618
al., Cancer Res., 50, 748 (1990). 6. Rubin, K., et al., Lancet, 1, 1353 (1988). 7. Reuterdahl, C., et al., Lab. Invest., 64, 321 (1991). 8. Raines, E.W., et al., Methods Enzymol., 109, 749 (1985).
Data Sheet - C9354
6. Williams, C., et al., Ann. N. Y. Acad. Sci., 889, 72 (1999). 7. Dubois, R. N., Aliment Pharmacol. Ther., 14, Suppl. 1, 64 (2000). 8. Langenbach, R., et al., Cell, 83, 483 (1995).
1/15